a go-to practice for pharmaceuticals and biotech clients’ patent litigation
nvolving blockbuster and other pharmaceutical drugs
Over the last 15 years, we have played a pivotal role in the majority of the high stake pharmaceutical cases before the Italian courts, shaping both case law and legislation in the field.
As a regular player before the Italian specialised IP Courts, and with solid experience working with other top-tier European law firms in defending the Italian arm of pan-European litigation, our life science team is in a formidable position to serve both Italian and international clients’ needs in this sector.
We are also regularly called upon to give advice on Italian and European anti-competitive issues in the pharmaceutical sector as well as handling regulatory matters such as data exclusivity, Italian market authorisations and matters relating to patent law.
Recent notable cases:
Assisting a global biopharmaceutical group in defending its patent rights concerning an innovative anticancer drug of crucial importance for the treatment of certain neoplasms
Assisting a Belgian-based leading pharmaceutical group in relation to patent litigation concerning one of the most important drugs of the group for the treatment of neurological disorders
Representing one of the most important biopharmaceutical multinationals in relation to a dispute concerning patent protection for the second medical use of an anticancer drug for the treatment of breast cancer
Representing a top-5 multinational pharmaceutical company in a dispute concerning the enforcement of patents protecting a blockbuster medicinal product for the treatment of diabetes
Assisting a German-based pharmaceutical multinational in a landmark patent dispute concerning the scope of the Bolar exemption
Representing the biggest Italian pharmaceutical company in a complex patent litigation relating to blockbuster drugs